Upal   Roy

Assistant Professor  

Upal Roy





Selected Publications


  • Upal Roy, Vadym Dorzd, Andriy Durygin, Jesse Rodriguez, Paul Barber, Venkata Atluri, Xiaohua Liu, Thomas Voss, Surendra Saxena, and Madhavan Nair. "Characterization of Nanodiamondbased anti-HIV drug Delivery to the Brain," Brownsville: Scientific Report (Nature publication) (2018).

  • A Kaushik, R Jayant, R Nikkhah-Moshaie, V Bhardwaj, Upal Roy, Z Huang, A Ruiz, A Yndart, V Atluri, N El-Hage, K Khalili, and M Nair. "Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers.," Scientific reports 6, (May 2016): 25309.

  • Upal Roy and B Bekhout, . "HIV Infection and Adipose Tissue-Resident Stem cells: Their Involvement in Pathology and Treatment.," Springer.: STEM CELLS AND CANCER STEM CELLS: Therapeutic Applications in Disease and Injury, , 13 , 2015: 21-34.

  • Upal Roy, H Ding, S Pilakka-Kanthikeel, A Raymond, V Atluri, A Yndart, E Kaftanovskaya, E Batrakova, M Agudelo, and M Nair. "Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.," International journal of nanomedicine 10, (September 2015): 5819-35.

  • Upal Roy, P Barber, Y Tse-Dinh, E Batrakova, D Mondal, and M Nair. "Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections.," Frontiers in microbiology 6, (September 2015): 948.

  • Upal Roy, V Atluri, M Agudelo, A Yndart, Z Huang, and M Nair. "DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.," Frontiers in microbiology 6, (July (3rd Quarter/Summer) 2015): 749.

  • Upal Roy, J Rodríguez, P Barber, J das Neves, B Sarmento, and M Nair. "The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials.," Nanomedicine (London, England) 10, no. 24 (January (1st Quarter/Winter) 2015): 3597-609.

  • Upal Roy, C Bulot, K Honer zu Bentrup, and D Mondal. "Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir.," PloS one 8, no. 10 (October (4th Quarter/Autumn) 2013): e75374.

  • N Gautam, Upal Roy, S Balkundi, P Puligujja, D Guo, N Smith, X Liu, B Lamberty, B Morsey, H Fox, J McMillan, H Gendelman, and Y Alnouti. "Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.," Antimicrobial agents and chemotherapy 57, no. 7 (July (3rd Quarter/Summer) 2013): 3110-20.

  • Upal Roy, J McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, S Gorantla, A Martinez-Skinner, J Meza, G Kanmogne, S Swindells, S Cohen, R Mosley, L Poluektova, and H Gendelman. "Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.," The Journal of infectious diseases 206, no. 10 (November 2012): 1577-88.



Selected Grants and Fellowships


  • Upal Roy. Development of Nanomedicine-based anti-HIV Drug Targeting Microfold (M) cells., Florida International University, $50,000.00 (2014 - 2016)

Current Courses

BMED 3223 12B - Independent Research III:
Syllabus
Course Evaluations
Textbooks
BMED 3224 4BR - Independent Research IV:
Syllabus
Course Evaluations
Textbooks
BMED 4440 1BR - Medical Microbiology:
Syllabus
Course Evaluations
Textbooks
BMED 4440 ABR - Medical Microbiology:
Syllabus
Course Evaluations
Textbooks
BMED 4240 1BR - Medical Microbiology:
Syllabus
Course Evaluations
Textbooks
BMED 4240 3BR - Medical Microbiology:
Syllabus
Course Evaluations
Textbooks
BMED 4240 2BR - Medical Microbiology:
Syllabus
Course Evaluations
Textbooks

Previous Courses